Psikiyatri
Synopsis
Anxiety disorders are persistent conditions characterized by excessive fear and avoidance, encompassing separation anxiety, selective mutism, specific phobia, social anxiety, panic disorder, agoraphobia, and generalized anxiety disorder. With a lifetime prevalence ranging from 4.8% to 31%, they frequently originate during childhood or adolescence. Female gender, familial history (30-40% heritability), and childhood traumas represent the primary risk factors. Neurobiologically, the amygdala, hippocampus, prefrontal cortex, and HPA axis modulate anxiety responses. Diagnosis relies on DSM-5 and ICD-10 criteria, requiring differential diagnosis from general medical conditions, substance/medication-induced symptoms, and other psychiatric disorders. Pharmacotherapy primarily utilizes SSRIs and SNRIs, which demonstrate anxiolytic onset within 2 to 4 weeks. Buspirone, benzodiazepines, pregabalin, and propranolol are reserved for specific clinical presentations or acute symptoms. Treatment regimens must carefully account for heightened adverse effect risks in elderly patients, as well as risk-benefit ratios in pediatric and pregnant populations. In addition to pharmacotherapy, psychoeducation and cognitive behavioral therapy (CBT) serve as highly effective interventions.
References
Baxter AJ, Scott KM, Vos T, et. al. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol. Med. 2013; 43: 897–910.
Beesdo-Baum K & Knappe S. Developmental epidemiology of anxiety disorders. Child Adolesc. Psychiatr. Clin. N. Am. 2012; 21: 457–478.
Giacobbe P & Flint A. Diagnosis and management of anxiety disorders. CONTINUUM: Lifelong Learning in Neurology. 2018;24(3):893-919.
Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues in clinical neuroscience. 2017;19(2): 93.
Craske MG, Stein MB, Eley TC, et al. Correction: anxiety disorders. Nature Reviews Disease Primers. 2017; 3(1): 1-1.
American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA):APA; 2013.